Biodegradable microspheres for protein delivery

被引:662
作者
Sinha, VR [1 ]
Trehan, A [1 ]
机构
[1] Panjab Univ, Univ Inst Pharmaceut Sci, Dept Pharmaceut, Chandigarh 160014, India
关键词
microspheres; delivery systems; protein stability;
D O I
10.1016/S0168-3659(03)00194-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In a very short time, since their emergence, the field of controlled delivery of proteins has grown immensely. Because of their relatively large size, they have low transdermal bioavailabilities. Oral bioavailability is generally poor since they are poorly absorbed and easily degraded by proteolytic enzymes in the gastrointestinal tract. Ocular and nasal delivery is also unfavorable due to degradation by enzymes present in eye tissues and nasal mucosa. Thus parenteral delivery is currently most demanding and suitable for delivery of such molecules. In systemic delivery of proteins, biodegradable microspheres as parenteral depot formulation occupy an important place because of several aspects like protection of sensitive proteins from degradation, prolonged or modified release, pulsatile release patterns. The main objective in developing controlled release protein injectables is avoidance of regular invasive doses which in turn provide patient compliance, comfort as well as control over blood levels. This review presents the outstanding contributions in field of biodegradable microspheres as protein delivery systems, their methods of preparation, drug release, stability, interaction with immune system and regulatory considerations. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:261 / 280
页数:20
相关论文
共 113 条
[21]   THE INFLUENCE OF EMULSIFYING AGENTS ON THE PHAGOCYTOSIS OF LIPID EMULSIONS BY MACROPHAGES [J].
DAVIS, SS ;
HANSRANI, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 23 (01) :69-77
[22]   PENETRATION ENHANCEMENT FOR POLYPEPTIDES THROUGH EPITHELIA .D. ROUTES OF DELIVERY - CASE-STUDIES .4. RATE-CONTROLLED RECTAL PEPTIDE DRUG ABSORPTION ENHANCEMENT [J].
DEBOER, AG ;
VANHOOGDALEM, EJ ;
BREIMER, DD .
ADVANCED DRUG DELIVERY REVIEWS, 1992, 8 (2-3) :237-251
[23]  
Fattal E., 2002, Annales Pharmaceutiques Francaises, V60, P44
[24]   Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides [J].
Fattal, E ;
Vauthier, C ;
Aynie, I ;
Nakada, Y ;
Lambert, G ;
Malvy, C ;
Couvreur, P .
JOURNAL OF CONTROLLED RELEASE, 1998, 53 (1-3) :137-143
[25]  
FOSTER GV, 1982, SAFETY EFFICACY TOPI, P99
[26]  
FUJITA SM, 1992, 7 ANN M AM ASS PHARM, P15
[27]   Enzyme loaded biodegradable microspheres in vitro ex vivo evaluation [J].
Genta, I ;
Perugini, P ;
Pavanetto, F ;
Maculotti, K ;
Modena, T ;
Casado, B ;
Lupi, A ;
Iadarola, P ;
Conti, B .
JOURNAL OF CONTROLLED RELEASE, 2001, 77 (03) :287-295
[28]  
GOURLAY SJ, 1978, J BIOMED MATER RES, V12, P219, DOI 10.1002/jbm.820120207
[29]   Preparation and evaluation of poly(L-lactic acid) microspheres containing rhEGF for chronic gastric ulcer healing [J].
Han, K ;
Lee, KD ;
Gao, ZG ;
Park, JS .
JOURNAL OF CONTROLLED RELEASE, 2001, 75 (03) :259-269
[30]  
Hanson MA., 1992, PHARM BIOTECHNOL, V3, P209